Company: ABBV
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001551152-25-000040
Chunk: 26

Company: AbbVie Inc.
Filing Date: 2025-08-04
Form: 10-Q
Item: Part I, Item 1
Chunk 26
---
 of contingent consideration liabilities4,313 2,136 Payments of contingent consideration liabilities(1,408)(876)Stock-based compensation589 566 Acquired IPR&D and milestones1,071 1,101 Non-cash litigation reserve adjustments, net of cash payments(750)27 Other, net96 (53)Changes in operating assets and liabilities, net of acquisitions:Accounts receivable(1,496)(524)Inventories(211)(127)Prepaid expenses and other assets(257)309 Accounts payable and other liabilities(181)(1,337)Income tax assets and liabilities, net(997)(1,456)Cash flows from operating activities6,788 6,311 Cash flows from investing activitiesAcquisitions of businesses, net of cash acquired(204)(9,199)Other acquisitions and investments(1,274)(1,033)Acquisitions of property and equipment(504)(434)Purchases of investment securities(22)(22)Sales and maturities of investment securities39 9 Other, net49 (11)Cash flows from investing activities(1,916)(10,690)Cash flows from financing activitiesNet change in commercial paper borrowings with original maturities of three months or less1,549 — Proceeds from issuance of other short-term borrowings4,007 5,008 Repayments of other short-term borrowings— (5,008)Proceeds from issuance of long-term debt3,994 14,963 Repayments of long-term debt and finance lease obligations(6,780)(3,448)Debt issuance costs(23)(99)Dividends paid(5,835)(5,522)Purchases of treasury stock(973)(1,333)Proceeds from the exercise of stock options61 137 Other, net32 24 Cash flows from financing activities(3,968)4,722 Effect of exchange rate changes on cash and equivalents39 (27)Net change in cash and equivalents943 316 Cash and equivalents, beginning of period5,524 12,814 Cash and equivalents, end of period$6,467 $13,130 

The accompanying notes are an integral part of these condensed consolidated financial statements.

2025 Form 10-Q | 5

AbbVie Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

Note 1 Basis of Presentation